𝔖 Bobbio Scriptorium
✦   LIBER   ✦

PMH38 A MODEL TO ASSESS THE COST-EFFECTIVENESS OF NEW TREATMENTS FOR DEPRESSION

✍ Scribed by P Sobocki; M Ekman; H Ågren; B Jönsson

Book ID
119594465
Publisher
John Wiley and Sons
Year
2006
Tongue
English
Weight
65 KB
Volume
9
Category
Article
ISSN
1098-3015

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Cost-effectiveness of new treatments for
Cost-effectiveness of new treatments for overactive bladder: The example of tolterodine, a new muscarinic agent: A Markov model
✍ Gisela Kobelt; Linus Jönsson; Anders Mattiasson 📂 Article 📅 1998 🏛 John Wiley and Sons 🌐 English ⚖ 72 KB 👁 2 views

Economic analyses of interventions for chronic diseases require evaluations over a long timeframe to illustrate the benefits and costs of treatments. Clinical trials are generally short and carried out in strictly controlled conditions. They are therefore of limited value for economic evaluation aim